Figure 1.
Proposed treatment algorithm for de novo metastatic breast cancer. TNBC = triple negative breast cancer, PDL-1 = programmed death ligand-1, BRCA mt = BRCA mutation, HER2 mt = HER2 mutation. + Currently unlicensed so only available within a clinical trial, * Can also be used in 2nd line in line with the EU license.
